Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/jpids/piab060 http://scihub22266oqcxt.onion/10.1093/jpids/piab060 34319393!8344528!34319393     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Pediatric+Infect+Dis+Soc 2021 ; 10 (10): 962-966 Nephropedia Template TP {{tp|p=34319393|t=2021. Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine |pdf=|usr=}}{{34319393}} gab.com Text Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine JO: J Pediatric Infect Dis Soc http://www.kidney.de/pget.php?&tw=1&pmid=34319393 #FOAvip On May 10, 2021, the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) was expanded to include adolescents (May 10, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use). We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children's Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine. Twit Text FOAVip Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine ????J Pediatric Infect Dis Soc http://www.kidney.de/pget.php?&tw=1&pmid=34319393 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34319393 #FOAvip English Wikipedia <ref>{{Cite pmid|34319393}}</ref> Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine #MMPMID34319393 Tano E; San Martin S; Girgis S; Martinez-Fernandez Y; Sanchez Vegas C J Pediatric Infect Dis Soc 2021[Nov]; 10 (10): 962-966 PMID34319393show ga On May 10, 2021, the Emergency Use Authorization of the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) was expanded to include adolescents (May 10, 2021. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use). We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children's Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine. |*COVID-19[MESH] |Adolescent[MESH] |BNT162 Vaccine[MESH] |COVID-19 Vaccines[MESH] |Child[MESH] |Humans[MESH]Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine (epmc).pdf DeepDyve Pubget Overpricing